Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-221865
Filing Date
2026-05-13
Accepted
2026-05-13 16:56:40
Documents
2
Period of Report
2026-05-11

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2282
2 EX-24 ck0000034956-ex24.htm EX-24 11599
  Complete submission text file 0001193125-26-221865.txt   15666
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM NC 27703
Business Address
STAAB THOMAS R II (Reporting) CIK: 0001230708 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 26974333